Health hazard evaluation determination report: HHE-78-131-586, Goodyear Tire and Rubber Company, Niagara Falls, New York.
Authors
Taft RM
Source
Cincinnati, OH: U.S. Department of Health, Education, and Welfare, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, HHE 78-131-586, 1979 Apr; :1-13
Environmental sampling and medical evaluations were conducted at the Goodyear Tire and Rubber Company (SIC-3011), Niagara Falls, New York, on October 25 and 26, 1978 to evaluate exposure among workers in the drying and bagging department to 4-morpholinyl-2- benzothiazole-disulfide (95329) (Kagarax-A). The Safety Committee Chairman of the Oil, Chemical and Atomic Workers International Union, reported that 19 employees were exposed to an irritating chemical substance, and that 68 cases of dermatitis had been reported in the past 5 years. Personal and area air sample concentrations for morpholine (110918) were below the environmental criteria of 20 parts per million. Samples for 2- mercaptobenzothiazole (149304) (MBT) were below the analytical limit of detection (0.035 milligrams per cubic meter, based on a 60 liter air sample). Wheal type lesions were found among workers due to skin contact with Kagarax-A. The investigators conclude that some workers may have become sensitized to the allergenic component (MBT) of Kagarax-A. Investigator recommendations for minimizing employee exposure to the chemical and preventing adverse health effects include: employee education; personal hygiene; use of laundry and eyewash facilities, personal protection equipment, and protective creams; improved housekeeping; physical examinations; and reporting of all cases of dermatitis to employee supervisors.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.